Real‐world glycaemic outcomes observed with the use of Medtronic <scp>780G</scp> , Tandem Control‐ <scp>IQ</scp> and Omnipod 5 automated insulin delivery systems
All three hybrid AID systems were associated with improvements in glycaemic outcomes in real-world use, supporting the role of AID systems in the management of T1D. Medtronic 780G use was associated with higher TIR increase compared with the other systems; however, these findings are based on measurements from different continuous glucose monitors between AID groups and cannot be used to infer superiority in glycaemic attainment.
Authors
- Ian F. Godsland (ORCID: https://orcid.org/0000-0002-0606-465X)
- Elisabeth Cresta
- Lavanta Farouk
- Lalantha Leelarathna (ORCID: https://orcid.org/0000-0001-9602-1962)
- Nick Oliver
- Parizad Avari
- Sathana Sivanantham
- Muhammad S. Khan
- Sara De Scolasticis
- Deeksha Reddy Lakshmareddy
- Monika Reddy
Institutions
- Imperial College Healthcare NHS Trust (GB)
- Imperial College London (GB)
- Keele University (GB)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1111/dme.70251
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Imperial College London
- Imperial College Healthcare NHS Trust
- NIHR Imperial Biomedical Research Centre